HomeCompareTGRNF vs MO

TGRNF vs MO: Dividend Comparison 2026

TGRNF yields 4.55% · MO yields 6.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MO wins by $47.6K in total portfolio value· pulled ahead in Year 6
10 years
TGRNF
TGRNF
● Live price
4.55%
Share price
$0.55
Annual div
$0.03
5Y div CAGR
9.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32.5K
Annual income
$1,748.22
Full TGRNF calculator →
MO
Altria Group Inc.
● Live price
6.36%
Share price
$65.99
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$80.1K
Annual income
$30,159.17
Full MO calculator →

Portfolio growth — TGRNF vs MO

📍 MO pulled ahead of the other in Year 6

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTGRNFMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TGRNF + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TGRNF pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TGRNF
Annual income on $10K today (after 15% tax)
$386.94/yr
After 10yr DRIP, annual income (after tax)
$1,485.99/yr
MO
Annual income on $10K today (after 15% tax)
$540.99/yr
After 10yr DRIP, annual income (after tax)
$25,635.29/yr
At 15% tax rate, MO beats the other by $24,149.31/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TGRNF + MO for your $10,000?

TGRNF: 50%MO: 50%
100% MO50/50100% TGRNF
Portfolio after 10yr
$56.3K
Annual income
$15,953.69/yr
Blended yield
28.33%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

TGRNF
No analyst data
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-7.2% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TGRNF buys
0
MO buys
0
No recent congressional trades found for TGRNF or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTGRNFMO
Forward yield4.55%6.36%
Annual dividend / share$0.03$4.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR9.4%22.6%
Portfolio after 10y$32.5K$80.1K
Annual income after 10y$1,748.22$30,159.17
Total dividends collected$10.0K$74.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: TGRNF vs MO ($10,000, DRIP)

YearTGRNF PortfolioTGRNF Income/yrMO PortfolioMO Income/yrGap
1$11,198$498.01$10,570$780.30+$628.00TGRNF
2$12,552$570.18$11,381$1,032.90+$1.2KTGRNF
3$14,084$653.46$12,535$1,392.73+$1.5KTGRNF
4$15,820$749.67$14,193$1,920.91+$1.6KTGRNF
5$17,788$860.93$16,618$2,723.68+$1.2KTGRNF
6← crossover$20,023$989.77$20,263$3,993.80$240.00MO
7$22,564$1,139.11$25,936$6,098.36$3.4KMO
8$25,456$1,312.45$35,166$9,775.01$9.7KMO
9$28,751$1,513.87$51,026$16,597.78$22.3KMO
10$32,512$1,748.22$80,113$30,159.17$47.6KMO

TGRNF vs MO: Complete Analysis 2026

TGRNFStock

Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products in Mainland China and Hong Kong. The company also cultivates, purchases, and sells Chinese medicinal raw materials; produces and sells ointment, tea drinks, and foot care products; sells medicinal products; and provides medical research and development, advertisement, and Chinese medical consultation and treatment services. In addition, it is involved in the technological development and sale of biological products, Chinese and Western medicines, cosmetics, and healthcare products; wholesale and retail sale of Chinese medicines and healthcare products; and internal and external surgery, medical examination, and hospital management activities. Further, it produces and processes biochemical products; extracts and processes plants; and produces food and daily chemical products, and medical services. The company was founded in 1669 and is based in Beijing, the People's Republic of China.

Full TGRNF Calculator →

MOConsumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this TGRNF vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TGRNF vs SCHDTGRNF vs JEPITGRNF vs OTGRNF vs KOTGRNF vs MAINTGRNF vs PMTGRNF vs BTITGRNF vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.